| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Alternative Dosing Schedules of Azacitidine: A Real-World Study Across South American Centers
|
Castelo, Lucas
|
|
|
24 |
6 |
p. 407-411
|
artikel
|
| 2 |
Comparison of the Efficacy Among Nilotinib, Dasatinib, Flumatinib and Imatinib in Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia Patients: A Real-World Multi-Center Retrospective Study
|
Zhang, Xiaoshuai
|
|
|
24 |
6 |
p. e257-e266
|
artikel
|
| 3 |
Dampening Logistics Creating Inequitable Access: A Major Threat Despite Advancements
|
Ayoobkhan, Fathima Shehnaz
|
|
|
24 |
6 |
p. 348-349
|
artikel
|
| 4 |
Editorial Board
|
|
|
|
24 |
6 |
p. A1-A2
|
artikel
|
| 5 |
Efficacy and Safety of Children With Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia After Anti-CD19 CAR T-Cell Therapy Without Bridging Transplantation
|
Shang, Qianwen
|
|
|
24 |
6 |
p. 392-399.e5
|
artikel
|
| 6 |
Hypomethylating Agents and Venetoclax for Acute Myeloid Leukemia Relapsed After Hematopoietic Stem Cell Transplant
|
Ionescu, Filip
|
|
|
24 |
6 |
p. 400-406
|
artikel
|
| 7 |
Long-term follow up of the combination of ofatumumab, high-dose methylprednisolone, and lenalidomide for untreated chronic lymphocytic leukemia with biomarker analysis
|
Chavez, Julio C
|
|
|
24 |
6 |
p. 382-391.e2
|
artikel
|
| 8 |
Outcome of Patients With Relapsed Acute Promyelocytic Leukemia
|
Sasaki, Koji
|
|
|
24 |
6 |
p. 375-381
|
artikel
|
| 9 |
PORT: A Randomized, Cross-Over, Phase 2 Study of Melflufen Peripheral Versus Central Intravenous Administration in Patients With Relapsed/Refractory Multiple Myeloma
|
Pour, Ludek
|
|
|
24 |
6 |
p. e267-e275.e2
|
artikel
|
| 10 |
Practical Aspects of Immunotherapy: A Report from the 20th International Myeloma Society (IMS) Annual Meeting
|
Raje, Noopur S.
|
|
|
24 |
6 |
p. 350-357
|
artikel
|
| 11 |
Recent Developments in Convenience of Administration of the Anti-CD38 Antibody Isatuximab: Subcutaneous Delivery and Fast Intravenous Infusion in Patients With Multiple Myeloma
|
Quach, Hang
|
|
|
24 |
6 |
p. 358-363
|
artikel
|
| 12 |
Safety and Toxicity Profiles of CAR T Cell Therapy in Non-Hodgkin Lymphoma: A Systematic Review and Meta-Analysis
|
Yamshon, Samuel
|
|
|
24 |
6 |
p. e235-e256.e2
|
artikel
|
| 13 |
SOHO State of the Art Updates and Next Questions | CTLs for Infections Following Stem Cell Transplantation
|
Rischall, Ariel
|
|
|
24 |
6 |
p. 340-347
|
artikel
|
| 14 |
SOHO State of the Art Updates and Next Questions | Next Questions: Acute Lymphoblastic Leukemia
|
Senapati, Jayastu
|
|
|
24 |
6 |
p. 333-339
|
artikel
|
| 15 |
Table of Contents
|
|
|
|
24 |
6 |
p. A3-A5
|
artikel
|
| 16 |
Treatment Pattern, Healthcare Resource Utilization and Symptom Burden Among Patients with Triple Class Exposed Multiple Myeloma: A Population-Based Cohort Study
|
Mian, Hira
|
|
|
24 |
6 |
p. e227-e234
|
artikel
|
| 17 |
Venetoclax and Cobimetinib in Relapsed/Refractory AML: A Phase 1b Trial
|
Konopleva, Marina Y.
|
|
|
24 |
6 |
p. 364-374
|
artikel
|
Tijdschrift beschrijving